Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusiong capacity) and ventilation and cardiac frequency during sub-maximal exercise

1. Measurements of transfer factor and sub-maximal exercise ventilation and cardiac frequency have been made on twenty women with iron-deficiency anaemia (Hb 8–9 g/100 ml) before and after ‘treatment’ with iron or placebo tablets and on control subjects.

2. The exercise ventilation, cardiac frequency and oxygen uptake were independent of haemoglobin concentration but the transfer factor was lower in the test than in control subjects and was increased by iron but not by placebo treatment. The results support the validity of the reaction-rate data for carbon monoxide with oxyhaemoglobin of Roughton & Forster (1957) despite evidence to the contrary from other studies.

3. In interpretation of sub-maximal exercise ventilation and cardiac frequency in iron-deficiency anaemia no allowance need be made for variation in haemoglobin concentration in the range 8–15 g/100 ml. For transfer factor a correction should be made by using a variant of the relationship of Roughton & Forster (1957).

Coronary heart disease treated and untreated by venous grafts

Images

Association of prolapse of posterior cusp of mitral valve and atrial septal defect

Images

Practolol in treatment of supraventricular cardiac dysrhythmias

Practolol (I.C.I. 50172) was used to treat supraventricular dysrhythmias in 32 patients with a rapid ventricular rate and with heart disease of varied aetiology. In 26 patients the average reduction in ventricular rate was 75 per minute, while immediate reversion to sinus rhythm occurred in three patients. The slowing effect was mainly due to a direct action on the atrioventricular node. The effectiveness of practolol was unrelated to the type of dysrhythmia or its aetiology. No serious adverse clinical effects were noted.